BMI Pharmaceuticals and Healthcare in Lebanon 2018
Healthcare spending in Lebanon is substantial with BMI revising its forecasts upwards. BMI estimates that healthcare spending will rise from $4.14 billion in 2017 to $4.32 billion in 2018. By 2022, BMI forecasts healthcare spending to reach $5.10 billion, experiencing a compounded annual growth rate (CAGR) of 4.2%. Per capita health care expenditure is expected to rise from $681 in 2017 to $868 in 2022.
Lebanon’s pharmaceutical sales will continue to grow in 2018. According to BMI’s estimates, pharmaceutical sales are forecast to rise by an annual 4.9% from $1.82 billion in 2017 to $1.91 billion in 2018. By 2022, BMI expects total pharmaceutical sales to amount to $2.32 billion which corresponds to a compound annual growth rate (CAGR) of 5.0%. According to BMI, Lebanon’s pharmaceutical sales are expected to account for 3.5% of GDP and 44% of healthcare expenditure in 2018, broadly in line with 2017 levels. BMI projects per capita pharmaceutical spending to increase from $299 in 2017 to $395 in 2022, still one of the highest in the region.
To read the full report, click below:
BMI Pharmaceuticals and Healthcare in Lebanon 2018
